SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-006600
Filing Date
2024-01-11
Accepted
2024-01-11 16:07:01
Documents
13
Period of Report
2024-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d636605d8k.htm   iXBRL 8-K 30513
2 EX-99.1 d636605dex991.htm EX-99.1 10602
  Complete submission text file 0001193125-24-006600.txt   169246

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20240105.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20240105_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20240105_pre.xml EX-101.PRE 11261
7 EXTRACTED XBRL INSTANCE DOCUMENT d636605d8k_htm.xml XML 3460
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 24529325
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)